Urinary β2-Microglobulin Is Associated With Acute Renal Allograft Rejection

American Journal of Kidney Diseases

Volumn 47, Issue 5, 2006, Pages 898-904

  Oetting, William S ^a,b   Rogers, Tyson B ^a,b   Krick, Thomas P ^a,b   Matas, Arthur J ^a,b   Ibrahim, Hassan N ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute rejection; biomarkers; proteomics

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREDICTION; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEINURIA; SENSITIVITY AND SPECIFICITY; URINALYSIS; ACUTE DISEASE; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; METHODOLOGY; URINE;

ACUTE DISEASE; ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URINALYSIS;

EID: 33646025496     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.01.034     Document Type: Article

References (25)

1. Matas A.J., Humar A., Payne W.D., et al. Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Ann Surg 230 (1999) 493-498
2. Weber J.A., and van Zanten A.P. Interferences in current methods for measurements of creatinine. Clin Chem 37 (1991) 695-700
3. Mizutani K., and Terasaki P.I. Serum creatinine levels in 10-year survivors of cadaveric kidney transplants. In: Cecka M., and Terasaki P. (Eds). Clinical Transplants (2003), UCLA Immunogenetics Center, Los Angeles, CA 441-448
4. Wilczek H.E. Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies. Transplantation 50 (1990) 790-797
5. Kolb L.G., Velosa J.A., Bergstralh E.J., and Offord K.P. Percutaneous renal allograft biopsy. A comparison of two needle types and analysis of risk factors. Transplantation 57 (1994) 1742-1746
6. Whittier W.L., and Korbet S.M. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 15 (2004) 142-147
7. Hariharan S., Kasiske B., Matas A., Cohen A., Harmon W., and Rabb H. Surrogate markers for long-term renal allograft survival. Am J Transplant 4 (2004) 1179-1183
8. Schaub S., Rush D., Wilkins J., et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15 (2004) 219-227
9. Schaub S., Wilkins J., Weiler T., Sangster K., Rush D., and Nickerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65 (2004) 323-322
10. Clarke W., Silverman B.C., Zhang Z., Chan D.W., Klein A.S., and Molmenti E.P. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 237 (2003) 660-664
11. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68 (1996) 850-858
12. 2-microglobulin occurring in human biological fluids. J Biol Chem 243 (1968) 4095-4103
13. Roelofs J.J., Rowshani A.T., van den Berg, et al. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection. Kidney Int 64 (2003) 1845-1853
14. Lederer S.R., Friedrich N., Regenbogen C., Getto R., Toepfer M., and Sitter T. Non-invasive monitoring of renal transplant recipients. Urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract 94 (2003) c19-c26
15. Teppo A.M., von Willebrand E., Honkanen E., Ahonen J., and Gronhagen-Riska C. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation. The origin and role of urinary sICAM-1. Transplantation 71 (2001) 1113-1119
16. Donadio C., Puccini R., Lucchesi A., Giordani R., and Rizzo G. Urinary excretion of proteins and tubular enzymes in renal transplant patients. Ren Fail 20 (1998) 707-715
17. Hoyer J., Preuss R., Riek R., Fricke L., and Steinhoff J. Quantitative determination of urine proteins. A rapid, noninvasive, sensitive, and inexpensive method to monitor renal grafts. Transplant Proc 27 (1995) 2571-2572
18. Sadeghi M., Daniel V., Wiesel M., Hergesell O., and Opelz G. High urine sIL-6R as a predictor of late graft failure in renal transplant recipients. Transplantation 76 (2003) 1190-1194
19. Han W.K., and Bonventre J. Biological markers for the early detection of acute kidney injury. Curr Opin Crit Care 10 (2004) 476-482
20. Kaden J., and Priesterjahn R. Increasing urinary IL-6 levels announce kidney graft rejection. Transpl Int 13 (2000) S34-S41 (suppl 1)
21. Gupta R.K., Jain M., and Sharma R.K. Serum and urinary interleukin-2 levels as predictors in acute renal allograft rejection. Indian J Med Res 119 (2004) 24-27
22. 2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 5 (2005) 726-738
23. 2-Microglobulin and renal graft rejection. Relationship to plasma creatinine during stable transplant function and graft rejection. Transplant Proc 16 (1984) 1613-1615
24. Winchester J.F., Salsberg J.A., and Levin N.W. Beta-2 microglobulin in ESRD. An in-depth review. Adv Renal Replace Ther 10 (2003) 279-309
25. Carvalho Matos A.C., Durao M.S., and Pacheco-Silva A. Serial beta-2 microglobulin measurement as an auxiliary method in the early diagnosis of cytomegalovirus infection in renal transplant patients. Transplant Proc 36 (2004) 894-895